\contentsline {chapter}{\numberline {4}Synthetic Lethal Analysis of Gene Expression Data}{6}{chapter.4}
\contentsline {section}{\numberline {4.1}Synthetic lethal genes in breast cancer}{7}{section.4.1}
\contentsline {subsection}{\numberline {4.1.1}Synthetic lethal pathways in breast cancer}{9}{subsection.4.1.1}
\contentsline {subsection}{\numberline {4.1.2}Expression profiles of synthetic lethal partners}{10}{subsection.4.1.2}
\contentsline {subsubsection}{\numberline {4.1.2.1}Subgroup pathway analysis}{13}{subsubsection.4.1.2.1}
\contentsline {section}{\numberline {4.2}Comparison of synthetic lethal gene candidates}{16}{section.4.2}
\contentsline {subsection}{\numberline {4.2.1}Comparison with siRNA screen candidates}{16}{subsection.4.2.1}
\contentsline {subsubsection}{\numberline {4.2.1.1}Comparison with correlation}{18}{subsubsection.4.2.1.1}
\contentsline {subsubsection}{\numberline {4.2.1.2}Comparison with viability}{18}{subsubsection.4.2.1.2}
\contentsline {subsubsection}{\numberline {4.2.1.3}Comparison with secondary screen siRNA screen candidates}{20}{subsubsection.4.2.1.3}
\contentsline {subsubsection}{\numberline {4.2.1.4}Comparison of screen at pathway level}{22}{subsubsection.4.2.1.4}
\contentsline {subsubsubsection}{\numberline {4.2.1.4.1}Resampling of genes for pathway enrichment}{24}{subsubsubsection.4.2.1.4.1}
\contentsline {subsubsection}{\numberline {4.2.1.5}Comparison of candidate SL Pathways}{27}{subsubsection.4.2.1.5}
\contentsline {section}{\numberline {4.3}Metagene Analysis}{27}{section.4.3}
\contentsline {subsection}{\numberline {4.3.1}Pathway expression}{27}{subsection.4.3.1}
\contentsline {subsection}{\numberline {4.3.2}Somatic mutation}{27}{subsection.4.3.2}
\contentsline {subsection}{\numberline {4.3.3}Synthetic lethal metagenes}{27}{subsection.4.3.3}
\contentsline {section}{\numberline {4.4}Mutation analysis}{27}{section.4.4}
\contentsline {section}{\numberline {4.5}Global Synthetic Lethality}{30}{section.4.5}
\contentsline {subsection}{\numberline {4.5.1}Hub Genes}{31}{subsection.4.5.1}
\contentsline {subsection}{\numberline {4.5.2}Hub Pathways}{31}{subsection.4.5.2}
\contentsline {section}{\numberline {4.6}Replication in stomach cancer}{31}{section.4.6}
\contentsline {subsection}{\numberline {4.6.1}Synthetic Lethal Genes and Pathways}{31}{subsection.4.6.1}
\contentsline {subsection}{\numberline {4.6.2}Synthetic Lethal Expression Profiles}{31}{subsection.4.6.2}
\contentsline {subsection}{\numberline {4.6.3}Comparison to Primary Screen}{31}{subsection.4.6.3}
\contentsline {subsubsection}{\numberline {4.6.3.1}Resampling Analysis}{31}{subsubsection.4.6.3.1}
\contentsline {subsection}{\numberline {4.6.4}Metagene Analysis}{31}{subsection.4.6.4}
\contentsline {section}{\numberline {4.7}Replication in cell line encyclopaedia}{31}{section.4.7}
\contentsline {section}{\numberline {4.8}Summary}{32}{section.4.8}
\contentsline {paragraph}{Aims}{42}{section*.54}
\contentsline {paragraph}{Summary}{43}{section*.55}
\contentsline {chapter}{\hbox to\@tempdima {\hfil }References}{49}{section*.55}
\contentsline {chapter}{\numberline {A}Sample Correlation}{51}{appendix.A}
\contentsline {chapter}{\numberline {B}Replicate Samples in TCGA Breast}{53}{appendix.B}
\contentsline {chapter}{\numberline {C}Software Used for Thesis}{57}{appendix.C}
\contentsline {chapter}{\numberline {D}Secondary Screen Data}{66}{appendix.D}
\contentsline {chapter}{\numberline {E}Mutation Analysis in Breast Cancer}{68}{appendix.E}
\contentsline {chapter}{\numberline {F}Expression Analysis in Stomach Cancer}{77}{appendix.F}
\contentsline {chapter}{\numberline {G}Mutation Analysis in Stomach Cancer}{78}{appendix.G}
